Full text
PDFPage 312

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bacopoulos N. G., Redmond D. E., Baulu J., Roth R. H. Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey). J Pharmacol Exp Ther. 1980 Jan;212(1):1–5. [PubMed] [Google Scholar]
- Bedford J. S., Mitchell J. B. The effect of hypoxia on the growth and radiation response of mammalian cells in culture. Br J Radiol. 1974 Oct;47(562):687–696. doi: 10.1259/0007-1285-47-562-687. [DOI] [PubMed] [Google Scholar]
- Begg A. C., Fu K. K., Kane L. J., Phillips T. L. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res. 1980 Jan;40(1):145–154. [PubMed] [Google Scholar]
- Brown J. M. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. Radiat Res. 1977 Dec;72(3):469–486. [PubMed] [Google Scholar]
- Brown J. M., Workman P. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res. 1980 Apr;82(1):171–190. [PubMed] [Google Scholar]
- Cawley J. C., Burns G. F., Hayhoe G. J. Hairy--cell leukaemia. Recent Results Cancer Res. 1980;72:1–123. doi: 10.1007/978-3-642-81437-2. [DOI] [PubMed] [Google Scholar]
- Clement J. J., Gorman M. S., Wodinsky I., Catane R., Johnson R. K. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. Cancer Res. 1980 Nov;40(11):4165–4172. [PubMed] [Google Scholar]
- Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gomer C. J., Johnson R. J. Relationship between misonidazole toxicity and core temperature in C3H mice. Radiat Res. 1979 May;78(2):329–333. [PubMed] [Google Scholar]
- Hirst D. G., Denekamp J. Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet. 1979 Jan;12(1):31–42. doi: 10.1111/j.1365-2184.1979.tb00111.x. [DOI] [PubMed] [Google Scholar]
- Koch C. J., Kruuv J., Frey H. E., Snyder R. A. Plateau phase in growth induced by hypoxia. Int J Radiat Biol Relat Stud Phys Chem Med. 1973 Jan;23(1):67–74. doi: 10.1080/09553007314550061. [DOI] [PubMed] [Google Scholar]
- Lefebvre Y., Hesseltine H. C. The peripheral white blood cells and metronidazole. JAMA. 1965 Oct 4;194(1):15–18. [PubMed] [Google Scholar]
- Roizin-Towle L., Hall E. J. Studies with bleomycin and misonidazole on aerated and hypoxic cells. Br J Cancer. 1978 Feb;37(2):254–260. doi: 10.1038/bjc.1978.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TILL J. E., McCULLOCH E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961 Feb;14:213–222. [PubMed] [Google Scholar]
- Tannock I. F. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU. Br J Cancer. 1980 Dec;42(6):871–880. doi: 10.1038/bjc.1980.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tannock I. F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer. 1968 Jun;22(2):258–273. doi: 10.1038/bjc.1968.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]
- Turner A. R., Allalunis M. J., Urtasun R. C., Pedersen J. E., Meeker B. E. Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice. Int J Radiat Oncol Biol Phys. 1980 Sep;6(9):1157–1162. doi: 10.1016/0360-3016(80)90168-6. [DOI] [PubMed] [Google Scholar]
- Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst. 1980 Mar;64(3):595–604. [PubMed] [Google Scholar]
- Twentyman P. R., Kallman R. F., Brown J. M. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1255–1260. doi: 10.1016/0360-3016(79)90649-7. [DOI] [PubMed] [Google Scholar]
- Twentyman P. R. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721. Br J Cancer. 1981 Jun;43(6):745–755. doi: 10.1038/bjc.1981.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. Br J Cancer. 1977 Feb;35(2):208–217. doi: 10.1038/bjc.1977.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R. Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1213–1220. doi: 10.1016/0360-3016(79)90641-2. [DOI] [PubMed] [Google Scholar]
- Urtasun R. C., Band P., Chapman J. D., Rabin H. R., Wilson A. F., Fryer C. G. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology. 1977 Mar;122(3):801–804. doi: 10.1148/122.3.801. [DOI] [PubMed] [Google Scholar]
- White R. A., Workman P., Brown J. M. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole. Radiat Res. 1980 Dec;84(3):542–561. [PubMed] [Google Scholar]
